Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV003558598 | SCV004296577 | likely pathogenic | not provided | 2023-03-13 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC12A6 protein function. ClinVar contains an entry for this variant (Variation ID: 637871). This missense change has been observed in individual(s) with hereditary motor and sensory neuropathy (PMID: 20020398). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 539 of the SLC12A6 protein (p.Gly539Asp). |
| Inherited Neuropathy Consortium | RCV000790220 | SCV000929612 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only |